MMP9 and breast cancer: In the study conducted by Kongtawelert et al.42in 2020, hesperidin (10–50 μM) suppressed the migration of MDA‐MB‐2 breast cancer cells via significantly reducing MMP‐2 and MMP‐9 activities.